Integrated genomics of ovarian xenograft tumor progression and chemotherapy response

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response

<p>Abstract</p> <p>Background</p> <p>Ovarian cancer is the most deadly gynecological cancer with a very poor prognosis. Xenograft mouse models have proven to be one very useful tool in testing candidate therapeutic agents and gene function <it>in vivo</it>....

Full description

Bibliographic Details
Main Authors:	Raphael Benjamin J, Singh Rakesh K, Ritz Anna, Kim Kyu K, Miller Daniel H, Hillenmeyer Sara, Fischer Andrew, Stuckey Ashley, Brard Laurent, Brodsky Alexander S
Format:	Article
Language:	English
Published:	BMC 2011-07-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/11/308

Similar Items

Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells
by: Singh Rakesh K, et al.
Published: (2010-02-01)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
by: Kim Kyu Kwang, et al.
Published: (2012-04-01)

Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model.
by: Richard G Moore, et al.
Published: (2012-01-01)

Correction: Iron(III)-Salophene: An Organometallic Compound with Selective Cytotoxic and Anti-Proliferative Properties in Platinum-Resistant Ovarian Cancer Cells.
by: Thilo S. Lange, et al.
Published: (2008-01-01)

Expression profiling of primary and metastatic ovarian tumors reveals differences indicative of aggressive disease.
by: Alexander S Brodsky, et al.
Published: (2014-01-01)

Correction: Identification of Ovarian Cancer Metastatic miRNAs.
by: Souriya Vang, et al.
Published: (2014-01-01)

Targeting HER2 in patient‐derived xenograft ovarian cancer models sensitizes tumors to chemotherapy
by: Faye R. Harris, et al.
Published: (2019-02-01)

Identification of ovarian cancer metastatic miRNAs.
by: Souriya Vang, et al.
Published: (2013-01-01)

Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study.
by: Vijayalakshmi N Ayyagari, et al.
Published: (2020-01-01)

Equine ovarian tissue xenografting: impacts of cooling, vitrification, and VEGF
by: Samara Silva Souza, et al.
Published: (2021-10-01)

Propranolol blocks osteosarcoma cell cycle progression, inhibits angiogenesis and slows xenograft growth in combination with cisplatin-based chemotherapy
by: Luisina M. Solernó, et al.
Published: (2022-09-01)

A Novel Antibody-Drug Conjugate Targeting Nectin-2 Suppresses Ovarian Cancer Progression in Mouse Xenograft Models
by: Yun Hee Sim, et al.
Published: (2022-10-01)

ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
by: Dong-Hoon Yeom, et al.
Published: (2020-12-01)

Overcoming platinum-acquired resistance in ovarian cancer patient-derived xenografts
by: Francesca Ricci, et al.
Published: (2019-06-01)

First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma.
by: Oystein Helland, et al.
Published: (2014-01-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

Factors that influence response classifications in chemotherapy treated patient-derived xenografts (PDX)
by: Joan E. Malcolm, et al.
Published: (2019-03-01)

Early Response of Prostate Carcinoma Xenografts to Docetaxel Chemotherapy Monitored With Diffusion MRI
by: Dominique Jennings, et al.
Published: (2002-01-01)

Comparison of Human Antral Follicles of Xenograft versus Ovarian Origin Reveals Disparate Molecular Signatures
by: Limor Man, et al.
Published: (2020-08-01)

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
by: Vijayalakshmi N Ayyagari, et al.
Published: (2017-01-01)

Zebrafish tumour xenograft models: a prognostic approach to epithelial ovarian cancer
by: Gabriel Lindahl, et al.
Published: (2024-02-01)

Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
by: Katrin Kleinmanns, et al.
Published: (2022-06-01)

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts
by: Kristina A. Butler, et al.
Published: (2017-08-01)

Patient-derived mammosphere and xenograft tumour initiation correlates with progression to metastasis.
by: Eyre, R, et al.
Published: (2016)

Neoadjuvant chemotherapy induces genomic and transcriptomic changes in ovarian cancer
by: Javellana, M, et al.
Published: (2021)

Sodium arsenite and hyperthermia modulate cisplatin-DNA damage responses and enhance platinum accumulation in murine metastatic ovarian cancer xenograft after hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Muenyi Clarisse S, et al.
Published: (2011-06-01)

Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient‐derived xenografts
by: Vilma Dembitz, et al.
Published: (2024-01-01)

Chemotherapy Associated Ovarian Failure
by: Davide Mauri, et al.
Published: (2020-12-01)

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model.
by: Christopher K McCann, et al.
Published: (2011-01-01)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
by: Ami Patel, et al.
Published: (2021-02-01)

Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts
by: Daniele Boso, et al.
Published: (2023-08-01)

Histologic and molecular analysis of patient derived xenografts of high-grade serous ovarian carcinoma
by: Ruifen Dong, et al.
Published: (2016-09-01)

Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
by: Clare eScott, et al.
Published: (2013-12-01)

Human Ovarian Follicles Xenografted in Immunoisolating Capsules Survive Long Term Implantation in Mice
by: Margaret A. Brunette, et al.
Published: (2022-06-01)

In situ Metabolic Profiling of Ovarian Cancer Tumor Xenografts: A Digital Pathology Approach
by: Ilaria Piga, et al.
Published: (2020-08-01)

Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study
by: Seokyung Shin, et al.
Published: (2021-10-01)

Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts
by: Demuytere J, et al.
Published: (2024-01-01)

Targeted drug conjugate systems for ovarian cancer chemotherapy
by: Omotola D. Ogundipe, et al.
Published: (2023-09-01)

Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis
by: Chen Qinghe, et al.
Published: (2008-01-01)

Resveratrol enhances antitumor activity of TRAIL in prostate cancer xenografts through activation of FOXO transcription factor.
by: Suthakar Ganapathy, et al.
Published: (2010-12-01)